Keystone Symposium on Alzheimer's Disease: beyond amyloid beta

被引：0
|
作者：
Fenili, Daniela [1 ]
Wyss-Coray, Tony [2 ,3 ]
McLaurin, JoAnne [1 ]
Jaeger, Philipp A. [2 ,4 ]
机构：
[1] Univ Toronto, Dept Lab Med & Pathobiol, Ctr Res Neurodegenerat Dis, 6 Queens Pk Crescent West, Toronto, ON M5S 3H2, Canada
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] VA Palo Alto Hlth Care Syst, Alameda, CA USA
[4] Free Univ Berlin, Berlin, Germany
来源：
FUTURE NEUROLOGY | 2010年 / 5卷 / 03期
关键词：
D O I：
10.2217/FNL.10.16
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The Keystone Symposium on Alzheimer's disease (AD), held in Copper Mountain, CO, USA, provided an opportunity for research scientists and industry experts in the field of AD and related disciplines to meet and discuss the future of AD research. This 5-day conference, comprised of 36 lectures and short talks, along with three poster sessions, covered a range of topics, including modeling AD progression, synaptic/neuronal dysfunction, neuronal regeneration, immunology, protein degradation, diagnostics and therapeutics. The primary goal of the symposia was to discuss new avenues of research and new ways to examine and interpret this disease - beyond amyloid beta.
引用
收藏
页码：353 / 355
页数：3
相关论文
共 50 条
  • [1] Amyloid-beta and tau protein beyond Alzheimer's disease
    Morteza Abyadeh
    Vivek Gupta
    Joao A.Paulo
    Arezoo Gohari Mahmoudabad
    Sina Shadfar
    Shahab Mirshahvaladi
    Veer Gupta
    Christine T.O.Nguyen
    David I.Finkelstein
    Yuyi You
    Paul A.Haynes
    Ghasem H.Salekdeh
    Stuart L.Graham
    Mehdi Mirzaei
    Neural Regeneration Research, 2024, (06) : 1262 - 1276
  • [2] Amyloid-beta and tau protein beyond Alzheimer's disease
    Abyadeh, Morteza
    Gupta, Vivek
    Paulo, Joao A.
    Mahmoudabad, Arezoo Gohari
    Shadfar, Sina
    Mirshahvaladi, Shahab
    Gupta, Veer
    Nguyen, Christine T. O.
    Finkelstein, David I.
    You, Yuyi
    Haynes, Paul A.
    Salekdeh, Ghasem H.
    Graham, Stuart L.
    Mirzaei, Mehdi
    NEURAL REGENERATION RESEARCH, 2024, 19 (06) : 1262 - 1276
  • [3] Amyloid Beta in Aging and Alzheimer's Disease
    Sehar, Ujala
    Rawat, Priyanka
    Reddy, Arubala P.
    Kopel, Jonathan
    Reddy, P. Hemachandra
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [4] Amyloid-beta peptide in atherogenesis: A novel role beyond Alzheimer's disease
    Li, L
    Wan, HQ
    Cao, DF
    Fukuchi, KI
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (05) : E18 - E18
  • [5] Amyloid Beta and MicroRNAs in Alzheimer's Disease
    Amakiri, Nnana
    Kubosumi, Aaron
    Tran, James
    Reddy, P. Hemachandra
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [6] Beta amyloid toxicity in Alzheimer's disease
    Gregory, GC
    Kwok, JB
    Xuereb, J
    Schofield, PR
    Halliday, GM
    NEUROBIOLOGY OF AGING, 2004, 25 : S157 - S158
  • [7] The molecular spectrum of amyloid-beta (Aβ) in neurodegenerative diseases beyond Alzheimer's disease
    Ichimata, Shojiro
    Yoshida, Koji
    Li, Jun
    Rogaeva, Ekaterina
    Lang, Anthony E.
    Kovacs, Gabor G.
    BRAIN PATHOLOGY, 2023,
  • [8] Beyond Amyloid - Widening the View on Alzheimer's Disease
    Behl, Christian
    Ziegler, Christine
    JOURNAL OF NEUROCHEMISTRY, 2017, 143 (04) : 394 - 395
  • [9] Biomarkers for Alzheimer's disease beyond amyloid and tau
    Zetterberg, Henrik
    Schott, Jonathan M.
    NATURE MEDICINE, 2019, 25 (02) : 201 - 203
  • [10] Biomarkers for Alzheimer’s disease beyond amyloid and tau
    Henrik Zetterberg
    Jonathan M. Schott
    Nature Medicine, 2019, 25 : 201 - 203
12345